Share this

PPD Leads Webinar on Adaptive Trial Design

Date: 30 Nov. 2012  |  Topic: Clinical Trials
Dirk Reitsma

Dirk Reitsma, M.D.

Vice President, Global Product Development
PPD

Niklas Morton

Niklas Morton

Vice President, Global Biostatistics, Programming and Medical Writing
PPD

Content Preview   

Adaptive trial design is critical in all phases of oncology drug development and helps overcome many hurdles of traditional study design. In a recent webinar with Applied Clinical Trials, PPD’s Dirk Reitsma, M.D., vice president, global product development, and Niklas Morton, vice president, global biostatistics, programming and medical writing, analyzed the incorporation of adaptive trial design in oncology trials. They were joined by Scott Berry, Ph.D., president and senior statistical scientist with Berry Consultants, to assess the early decision making benefits that are critical to the decreasing drug development time and providing increased benefit to patients.

Connect With Us

We want to hear from you. 

Investigators Needed

Register in PPD’s database.  

Stay Connected

RSS LinkedIn
Contact Site Map Legal Notices Privacy Policy

© 2014 Pharmaceutical Product Development, LLC. All rights reserved.